nodes	percent_of_prediction	percent_of_DWPC	metapath
Nilotinib—MAPK8—Activation of BIM and translocation to mitochondria—BCL2L11—sclerosing cholangitis	0.0918	0.139	CbGpPWpGaD
Nilotinib—HCK—amb2 Integrin signaling—MST1—sclerosing cholangitis	0.0242	0.0367	CbGpPWpGaD
Nilotinib—CA9—gall bladder—sclerosing cholangitis	0.0233	0.068	CbGeAlD
Nilotinib—PDGFRA—gall bladder—sclerosing cholangitis	0.0186	0.0545	CbGeAlD
Nilotinib—MAPK8—Activation of BH3-only proteins—BCL2L11—sclerosing cholangitis	0.0168	0.0256	CbGpPWpGaD
Nilotinib—MAPK8—pancreas—sclerosing cholangitis	0.0165	0.0481	CbGeAlD
Nilotinib—MAPK8—FoxO family signaling—MST1—sclerosing cholangitis	0.0156	0.0237	CbGpPWpGaD
Nilotinib—CA9—Regulation of gene expression by Hypoxia-inducible Factor—HIF1A—sclerosing cholangitis	0.0153	0.0232	CbGpPWpGaD
Nilotinib—KIT—gall bladder—sclerosing cholangitis	0.0149	0.0436	CbGeAlD
Nilotinib—PDGFRB—gall bladder—sclerosing cholangitis	0.0146	0.0426	CbGeAlD
Nilotinib—TEK—Wnt Signaling Pathway Netpath—TCF4—sclerosing cholangitis	0.0139	0.0211	CbGpPWpGaD
Nilotinib—FRK—liver—sclerosing cholangitis	0.0137	0.0402	CbGeAlD
Nilotinib—TIE1—Rac1/Pak1/p38/MMP-2 pathway—NOS2—sclerosing cholangitis	0.0129	0.0196	CbGpPWpGaD
Nilotinib—MAPK8—Intrinsic Pathway for Apoptosis—BCL2L11—sclerosing cholangitis	0.012	0.0183	CbGpPWpGaD
Nilotinib—CDC42BPB—liver—sclerosing cholangitis	0.0116	0.0339	CbGeAlD
Nilotinib—MAPK11—CDO in myogenesis—TCF4—sclerosing cholangitis	0.0114	0.0174	CbGpPWpGaD
Nilotinib—TEK—Angiogenesis—HIF1A—sclerosing cholangitis	0.0114	0.0174	CbGpPWpGaD
Nilotinib—MAPK8—NRAGE signals death through JNK—BCL2L11—sclerosing cholangitis	0.0105	0.016	CbGpPWpGaD
Nilotinib—MAPK8—liver—sclerosing cholangitis	0.0105	0.0306	CbGeAlD
Nilotinib—EPHB4—pancreas—sclerosing cholangitis	0.00991	0.029	CbGeAlD
Nilotinib—MAPK8—FoxO family signaling—BCL2L11—sclerosing cholangitis	0.00982	0.0149	CbGpPWpGaD
Nilotinib—EPHA2—pancreas—sclerosing cholangitis	0.00972	0.0284	CbGeAlD
Nilotinib—LYN—liver—sclerosing cholangitis	0.00966	0.0283	CbGeAlD
Nilotinib—MAPK8—Apoptosis Modulation and Signaling—TNFRSF25—sclerosing cholangitis	0.00949	0.0144	CbGpPWpGaD
Nilotinib—BLK—Apoptosis Modulation and Signaling—TNFRSF25—sclerosing cholangitis	0.00949	0.0144	CbGpPWpGaD
Nilotinib—TEK—pancreas—sclerosing cholangitis	0.00948	0.0277	CbGeAlD
Nilotinib—MAPK8—ErbB Signaling Pathway—BCL2L11—sclerosing cholangitis	0.00909	0.0138	CbGpPWpGaD
Nilotinib—TIE1—liver—sclerosing cholangitis	0.00908	0.0266	CbGeAlD
Nilotinib—MAPK8—Wnt Signaling Pathway Netpath—TCF4—sclerosing cholangitis	0.009	0.0137	CbGpPWpGaD
Nilotinib—CA2—gall bladder—sclerosing cholangitis	0.00883	0.0258	CbGeAlD
Nilotinib—BRAF—liver—sclerosing cholangitis	0.0087	0.0255	CbGeAlD
Nilotinib—ABL1—CDO in myogenesis—TCF4—sclerosing cholangitis	0.00857	0.013	CbGpPWpGaD
Nilotinib—MAPK8—Cell death signalling via NRAGE, NRIF and NADE—BCL2L11—sclerosing cholangitis	0.00825	0.0125	CbGpPWpGaD
Nilotinib—MAPK14—CDO in myogenesis—TCF4—sclerosing cholangitis	0.00817	0.0124	CbGpPWpGaD
Nilotinib—HCK—liver—sclerosing cholangitis	0.00793	0.0232	CbGeAlD
Nilotinib—ABL2—liver—sclerosing cholangitis	0.00788	0.0231	CbGeAlD
Nilotinib—MAPK8—p75(NTR)-mediated signaling—BCL2L11—sclerosing cholangitis	0.00747	0.0114	CbGpPWpGaD
Nilotinib—CA3—liver—sclerosing cholangitis	0.00712	0.0208	CbGeAlD
Nilotinib—KIT—pancreas—sclerosing cholangitis	0.00687	0.0201	CbGeAlD
Nilotinib—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—sclerosing cholangitis	0.00685	0.0104	CbGpPWpGaD
Nilotinib—MAPK8—AGE/RAGE pathway—ALPL—sclerosing cholangitis	0.00683	0.0104	CbGpPWpGaD
Nilotinib—CA9—Cellular response to hypoxia—HIF1A—sclerosing cholangitis	0.00675	0.0103	CbGpPWpGaD
Nilotinib—PDGFRB—pancreas—sclerosing cholangitis	0.00671	0.0196	CbGeAlD
Nilotinib—MAPK14—liver—sclerosing cholangitis	0.00665	0.0195	CbGeAlD
Nilotinib—LCK—liver—sclerosing cholangitis	0.00662	0.0194	CbGeAlD
Nilotinib—FGR—liver—sclerosing cholangitis	0.00662	0.0194	CbGeAlD
Nilotinib—MAPK8—p75 NTR receptor-mediated signalling—BCL2L11—sclerosing cholangitis	0.00651	0.00989	CbGpPWpGaD
Nilotinib—CA14—liver—sclerosing cholangitis	0.00647	0.0189	CbGeAlD
Nilotinib—EPHB4—liver—sclerosing cholangitis	0.0063	0.0184	CbGeAlD
Nilotinib—CA1—pancreas—sclerosing cholangitis	0.00628	0.0184	CbGeAlD
Nilotinib—EPHA2—liver—sclerosing cholangitis	0.00618	0.0181	CbGeAlD
Nilotinib—ABCB1—ABC-family proteins mediated transport—CFTR—sclerosing cholangitis	0.00604	0.00917	CbGpPWpGaD
Nilotinib—TEK—liver—sclerosing cholangitis	0.00603	0.0176	CbGeAlD
Nilotinib—MAPK8—Apoptosis Modulation and Signaling—BCL2L11—sclerosing cholangitis	0.00599	0.0091	CbGpPWpGaD
Nilotinib—BLK—Apoptosis Modulation and Signaling—BCL2L11—sclerosing cholangitis	0.00599	0.0091	CbGpPWpGaD
Nilotinib—ABL1—pancreas—sclerosing cholangitis	0.00598	0.0175	CbGeAlD
Nilotinib—MAPK8—Corticotropin-releasing hormone—TCF4—sclerosing cholangitis	0.0057	0.00866	CbGpPWpGaD
Nilotinib—PDGFRA—liver—sclerosing cholangitis	0.00546	0.016	CbGeAlD
Nilotinib—ABL1—ErbB Signaling Pathway—BCL2L11—sclerosing cholangitis	0.00543	0.00825	CbGpPWpGaD
Nilotinib—MAPK11—p73 transcription factor network—BCL2L11—sclerosing cholangitis	0.00534	0.00812	CbGpPWpGaD
Nilotinib—MAPK8—Integrated Pancreatic Cancer Pathway—MST1—sclerosing cholangitis	0.00525	0.00797	CbGpPWpGaD
Nilotinib—UGT1A1—liver—sclerosing cholangitis	0.00521	0.0153	CbGeAlD
Nilotinib—MAPK8—DNA Damage Response (only ATM dependent)—BCL2L11—sclerosing cholangitis	0.00518	0.00787	CbGpPWpGaD
Nilotinib—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—sclerosing cholangitis	0.00505	0.00768	CbGpPWpGaD
Nilotinib—PDGFRA—Angiogenesis—HIF1A—sclerosing cholangitis	0.00503	0.00764	CbGpPWpGaD
Nilotinib—CYP3A4—Farnesoid X Receptor  Pathway—ABCB4—sclerosing cholangitis	0.00496	0.00753	CbGpPWpGaD
Nilotinib—MAP2K5—liver—sclerosing cholangitis	0.00493	0.0144	CbGeAlD
Nilotinib—CSF1R—liver—sclerosing cholangitis	0.00481	0.0141	CbGeAlD
Nilotinib—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—sclerosing cholangitis	0.00472	0.00717	CbGpPWpGaD
Nilotinib—TEK—Rac1/Pak1/p38/MMP-2 pathway—NOS2—sclerosing cholangitis	0.00458	0.00695	CbGpPWpGaD
Nilotinib—BRAF—Corticotropin-releasing hormone—TCF4—sclerosing cholangitis	0.0045	0.00684	CbGpPWpGaD
Nilotinib—KIT—liver—sclerosing cholangitis	0.00437	0.0128	CbGeAlD
Nilotinib—PDGFRB—liver—sclerosing cholangitis	0.00427	0.0125	CbGeAlD
Nilotinib—EPHA3—NRF2 pathway—GGT1—sclerosing cholangitis	0.00424	0.00644	CbGpPWpGaD
Nilotinib—MAPK14—Angiogenesis—HIF1A—sclerosing cholangitis	0.00421	0.00639	CbGpPWpGaD
Nilotinib—MAPK8—BDNF signaling pathway—BCL2L11—sclerosing cholangitis	0.00415	0.0063	CbGpPWpGaD
Nilotinib—CA2—pancreas—sclerosing cholangitis	0.00407	0.0119	CbGeAlD
Nilotinib—ABL1—p73 transcription factor network—BCL2L11—sclerosing cholangitis	0.004	0.00608	CbGpPWpGaD
Nilotinib—CA1—liver—sclerosing cholangitis	0.004	0.0117	CbGeAlD
Nilotinib—MAPK11—Signaling mediated by p38-alpha and p38-beta—NOS2—sclerosing cholangitis	0.00396	0.00602	CbGpPWpGaD
Nilotinib—MAP2K5—BDNF signaling pathway—BCL2L11—sclerosing cholangitis	0.00394	0.00599	CbGpPWpGaD
Nilotinib—MAPK8—Apoptosis—BCL2L11—sclerosing cholangitis	0.00391	0.00594	CbGpPWpGaD
Nilotinib—MAPK14—AGE/RAGE pathway—ALPL—sclerosing cholangitis	0.00388	0.0059	CbGpPWpGaD
Nilotinib—MAPK14—p73 transcription factor network—BCL2L11—sclerosing cholangitis	0.00381	0.00579	CbGpPWpGaD
Nilotinib—ABL1—liver—sclerosing cholangitis	0.0038	0.0111	CbGeAlD
Nilotinib—MAPK8—BDNF signaling pathway—ALPL—sclerosing cholangitis	0.00366	0.00556	CbGpPWpGaD
Nilotinib—PDGFRA—Integrated Pancreatic Cancer Pathway—MST1—sclerosing cholangitis	0.00357	0.00542	CbGpPWpGaD
Nilotinib—MAP2K5—BDNF signaling pathway—ALPL—sclerosing cholangitis	0.00348	0.00528	CbGpPWpGaD
Nilotinib—MAPK8—Oncostatin M Signaling Pathway—HIF1A—sclerosing cholangitis	0.00333	0.00506	CbGpPWpGaD
Nilotinib—EPHA2—NRF2 pathway—GGT1—sclerosing cholangitis	0.0033	0.00501	CbGpPWpGaD
Nilotinib—MAPK8—AGE/RAGE pathway—HIF1A—sclerosing cholangitis	0.00329	0.005	CbGpPWpGaD
Nilotinib—MAPK8—ATF-2 transcription factor network—NOS2—sclerosing cholangitis	0.00328	0.00498	CbGpPWpGaD
Nilotinib—MAPK14—Corticotropin-releasing hormone—TCF4—sclerosing cholangitis	0.00324	0.00493	CbGpPWpGaD
Nilotinib—ABL1—Integrated Pancreatic Cancer Pathway—MST1—sclerosing cholangitis	0.00313	0.00476	CbGpPWpGaD
Nilotinib—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—sclerosing cholangitis	0.00311	0.00473	CbGpPWpGaD
Nilotinib—CA9—HIF-1-alpha transcription factor network—HIF1A—sclerosing cholangitis	0.0031	0.00472	CbGpPWpGaD
Nilotinib—ABL1—DNA Damage Response (only ATM dependent)—BCL2L11—sclerosing cholangitis	0.00309	0.0047	CbGpPWpGaD
Nilotinib—EPHA4—Spinal Cord Injury—NOS2—sclerosing cholangitis	0.00304	0.00461	CbGpPWpGaD
Nilotinib—MAPK8—AGE/RAGE pathway—NOS2—sclerosing cholangitis	0.003	0.00455	CbGpPWpGaD
Nilotinib—MAPK14—Integrated Pancreatic Cancer Pathway—MST1—sclerosing cholangitis	0.00298	0.00453	CbGpPWpGaD
Nilotinib—MAPK8—Rac1/Pak1/p38/MMP-2 pathway—NOS2—sclerosing cholangitis	0.00296	0.0045	CbGpPWpGaD
Nilotinib—MAPK14—Signaling mediated by p38-alpha and p38-beta—NOS2—sclerosing cholangitis	0.00283	0.0043	CbGpPWpGaD
Nilotinib—CA9—HIF-1-alpha transcription factor network—NOS2—sclerosing cholangitis	0.00282	0.00429	CbGpPWpGaD
Nilotinib—EPHB3—Developmental Biology—TCF4—sclerosing cholangitis	0.00282	0.00428	CbGpPWpGaD
Nilotinib—FGR—Platelet homeostasis—NOS2—sclerosing cholangitis	0.00261	0.00397	CbGpPWpGaD
Nilotinib—MAPK11—ATF-2 transcription factor network—NOS2—sclerosing cholangitis	0.00261	0.00397	CbGpPWpGaD
Nilotinib—CA2—liver—sclerosing cholangitis	0.00259	0.00758	CbGeAlD
Nilotinib—EPHA3—Developmental Biology—TCF4—sclerosing cholangitis	0.00251	0.00382	CbGpPWpGaD
Nilotinib—ABL2—Developmental Biology—TCF4—sclerosing cholangitis	0.00251	0.00382	CbGpPWpGaD
Nilotinib—CA3—Metabolism—ABCB4—sclerosing cholangitis	0.00247	0.00375	CbGpPWpGaD
Nilotinib—CYP2C8—liver—sclerosing cholangitis	0.00247	0.00722	CbGeAlD
Nilotinib—EPHA8—Developmental Biology—TCF4—sclerosing cholangitis	0.00242	0.00368	CbGpPWpGaD
Nilotinib—ABCG2—liver—sclerosing cholangitis	0.0024	0.00702	CbGeAlD
Nilotinib—EPHA4—Developmental Biology—TCF4—sclerosing cholangitis	0.0024	0.00364	CbGpPWpGaD
Nilotinib—EPHB4—Developmental Biology—TCF4—sclerosing cholangitis	0.0024	0.00364	CbGpPWpGaD
Nilotinib—MAPK8—Signaling by NGF—BCL2L11—sclerosing cholangitis	0.0024	0.00364	CbGpPWpGaD
Nilotinib—MAPK14—BDNF signaling pathway—BCL2L11—sclerosing cholangitis	0.00236	0.00358	CbGpPWpGaD
Nilotinib—MAPK11—Rac1/Pak1/p38/MMP-2 pathway—NOS2—sclerosing cholangitis	0.00236	0.00358	CbGpPWpGaD
Nilotinib—EPHB2—Developmental Biology—TCF4—sclerosing cholangitis	0.00232	0.00353	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling by NGF—BCL2L11—sclerosing cholangitis	0.00228	0.00346	CbGpPWpGaD
Nilotinib—EPHB6—Developmental Biology—TCF4—sclerosing cholangitis	0.00225	0.00342	CbGpPWpGaD
Nilotinib—PDGFRA—ATF-2 transcription factor network—NOS2—sclerosing cholangitis	0.00223	0.00339	CbGpPWpGaD
Nilotinib—CYP2B6—liver—sclerosing cholangitis	0.00221	0.00647	CbGeAlD
Nilotinib—CYP2C9—liver—sclerosing cholangitis	0.00219	0.00641	CbGeAlD
Nilotinib—EPHA6—Developmental Biology—TCF4—sclerosing cholangitis	0.00212	0.00322	CbGpPWpGaD
Nilotinib—UGT1A1—Phase II conjugation—GGT1—sclerosing cholangitis	0.00211	0.00321	CbGpPWpGaD
Nilotinib—MAPK14—BDNF signaling pathway—ALPL—sclerosing cholangitis	0.00208	0.00316	CbGpPWpGaD
Nilotinib—CYP3A4—Aflatoxin activation and detoxification—GGT1—sclerosing cholangitis	0.00203	0.00309	CbGpPWpGaD
Nilotinib—EPHA2—Developmental Biology—TCF4—sclerosing cholangitis	0.00195	0.00297	CbGpPWpGaD
Nilotinib—MAPK11—Signaling by NGF—BCL2L11—sclerosing cholangitis	0.00191	0.0029	CbGpPWpGaD
Nilotinib—MAPK14—Oncostatin M Signaling Pathway—HIF1A—sclerosing cholangitis	0.0019	0.00288	CbGpPWpGaD
Nilotinib—BRAF—Signaling by NGF—BCL2L11—sclerosing cholangitis	0.00189	0.00287	CbGpPWpGaD
Nilotinib—MAPK14—AGE/RAGE pathway—HIF1A—sclerosing cholangitis	0.00187	0.00284	CbGpPWpGaD
Nilotinib—MAPK14—ATF-2 transcription factor network—NOS2—sclerosing cholangitis	0.00186	0.00283	CbGpPWpGaD
Nilotinib—ABCB1—pancreas—sclerosing cholangitis	0.00186	0.00544	CbGeAlD
Nilotinib—MAPK14—IL12-mediated signaling events—NOS2—sclerosing cholangitis	0.00184	0.00279	CbGpPWpGaD
Nilotinib—CYP2C8—Arachidonic acid metabolism—GGT1—sclerosing cholangitis	0.00175	0.00265	CbGpPWpGaD
Nilotinib—LCK—Notch Signaling Pathway—HIF1A—sclerosing cholangitis	0.00172	0.00262	CbGpPWpGaD
Nilotinib—KIT—Signaling by NGF—BCL2L11—sclerosing cholangitis	0.00172	0.00261	CbGpPWpGaD
Nilotinib—MAPK14—AGE/RAGE pathway—NOS2—sclerosing cholangitis	0.0017	0.00259	CbGpPWpGaD
Nilotinib—MAPK14—Rac1/Pak1/p38/MMP-2 pathway—NOS2—sclerosing cholangitis	0.00168	0.00256	CbGpPWpGaD
Nilotinib—CYP3A4—liver—sclerosing cholangitis	0.00167	0.00489	CbGeAlD
Nilotinib—CYP2D6—liver—sclerosing cholangitis	0.00164	0.00481	CbGeAlD
Nilotinib—PDGFRA—Signaling by NGF—BCL2L11—sclerosing cholangitis	0.00163	0.00247	CbGpPWpGaD
Nilotinib—CA14—Metabolism—ABCB4—sclerosing cholangitis	0.00159	0.00242	CbGpPWpGaD
Nilotinib—LCK—IL12-mediated signaling events—NOS2—sclerosing cholangitis	0.00159	0.00241	CbGpPWpGaD
Nilotinib—ABCG2—HIF-1-alpha transcription factor network—HIF1A—sclerosing cholangitis	0.00157	0.00238	CbGpPWpGaD
Nilotinib—CA6—Metabolism—ABCB4—sclerosing cholangitis	0.00155	0.00236	CbGpPWpGaD
Nilotinib—MAPK14—Platelet homeostasis—NOS2—sclerosing cholangitis	0.00149	0.00226	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling by NGF—BCL2L11—sclerosing cholangitis	0.00147	0.00223	CbGpPWpGaD
Nilotinib—CA7—Metabolism—ABCB4—sclerosing cholangitis	0.00145	0.0022	CbGpPWpGaD
Nilotinib—ABCG2—HIF-1-alpha transcription factor network—NOS2—sclerosing cholangitis	0.00143	0.00217	CbGpPWpGaD
Nilotinib—CYP2C9—Arachidonic acid metabolism—GGT1—sclerosing cholangitis	0.00142	0.00216	CbGpPWpGaD
Nilotinib—UGT1A1—NRF2 pathway—GGT1—sclerosing cholangitis	0.00141	0.00214	CbGpPWpGaD
Nilotinib—MAPK14—Signaling by NGF—BCL2L11—sclerosing cholangitis	0.00136	0.00207	CbGpPWpGaD
Nilotinib—ABCB1—Integrated Pancreatic Cancer Pathway—MST1—sclerosing cholangitis	0.00135	0.00205	CbGpPWpGaD
Nilotinib—CA12—Metabolism—ABCB4—sclerosing cholangitis	0.00134	0.00204	CbGpPWpGaD
Nilotinib—UGT1A1—Biological oxidations—GGT1—sclerosing cholangitis	0.00123	0.00188	CbGpPWpGaD
Nilotinib—MAPK8—Circadian rythm related genes—NOS2—sclerosing cholangitis	0.00123	0.00187	CbGpPWpGaD
Nilotinib—MAPK11—Developmental Biology—TCF4—sclerosing cholangitis	0.00118	0.0018	CbGpPWpGaD
Nilotinib—ABCB1—liver—sclerosing cholangitis	0.00118	0.00346	CbGeAlD
Nilotinib—LCK—Signaling by NGF—BCL2L11—sclerosing cholangitis	0.00118	0.00179	CbGpPWpGaD
Nilotinib—CA3—Metabolism—GOT2—sclerosing cholangitis	0.00117	0.00178	CbGpPWpGaD
Nilotinib—ABCG2—Transmembrane transport of small molecules—CFTR—sclerosing cholangitis	0.00117	0.00177	CbGpPWpGaD
Nilotinib—MAPK8—Cellular responses to stress—HIF1A—sclerosing cholangitis	0.00109	0.00165	CbGpPWpGaD
Nilotinib—CA4—Metabolism—ABCB4—sclerosing cholangitis	0.00107	0.00163	CbGpPWpGaD
Nilotinib—CA2—Metabolism—ABCB4—sclerosing cholangitis	0.00103	0.00156	CbGpPWpGaD
Nilotinib—CA9—Cellular responses to stress—HIF1A—sclerosing cholangitis	0.00102	0.00156	CbGpPWpGaD
Nilotinib—CA3—Metabolism—GGT1—sclerosing cholangitis	0.00101	0.00154	CbGpPWpGaD
Nilotinib—CA3—Metabolism—GOT1—sclerosing cholangitis	0.00101	0.00154	CbGpPWpGaD
Nilotinib—CA1—Metabolism—ABCB4—sclerosing cholangitis	0.000983	0.00149	CbGpPWpGaD
Nilotinib—TEK—Hemostasis—NOS2—sclerosing cholangitis	0.000908	0.00138	CbGpPWpGaD
Nilotinib—LYN—Developmental Biology—TCF4—sclerosing cholangitis	0.000892	0.00135	CbGpPWpGaD
Nilotinib—ABL1—Developmental Biology—TCF4—sclerosing cholangitis	0.000887	0.00135	CbGpPWpGaD
Nilotinib—MAPK11—Cellular responses to stress—HIF1A—sclerosing cholangitis	0.000866	0.00131	CbGpPWpGaD
Nilotinib—CA9—Metabolism—ABCB4—sclerosing cholangitis	0.000865	0.00131	CbGpPWpGaD
Nilotinib—ABCB1—HIF-1-alpha transcription factor network—HIF1A—sclerosing cholangitis	0.000848	0.00129	CbGpPWpGaD
Nilotinib—MAPK14—Developmental Biology—TCF4—sclerosing cholangitis	0.000845	0.00128	CbGpPWpGaD
Nilotinib—ABCB1—HIF-1-alpha transcription factor network—NOS2—sclerosing cholangitis	0.000771	0.00117	CbGpPWpGaD
Nilotinib—CYP2B6—Biological oxidations—GGT1—sclerosing cholangitis	0.000768	0.00117	CbGpPWpGaD
Nilotinib—CA14—Metabolism—GOT2—sclerosing cholangitis	0.000756	0.00115	CbGpPWpGaD
Nilotinib—CA6—Metabolism—GOT2—sclerosing cholangitis	0.000737	0.00112	CbGpPWpGaD
Nilotinib—CA7—Metabolism—GOT2—sclerosing cholangitis	0.000688	0.00105	CbGpPWpGaD
Nilotinib—CA14—Metabolism—GGT1—sclerosing cholangitis	0.000653	0.000992	CbGpPWpGaD
Nilotinib—CA14—Metabolism—GOT1—sclerosing cholangitis	0.000653	0.000992	CbGpPWpGaD
Nilotinib—CYP2C8—Biological oxidations—GGT1—sclerosing cholangitis	0.00065	0.000988	CbGpPWpGaD
Nilotinib—CA12—Metabolism—GOT2—sclerosing cholangitis	0.000637	0.000968	CbGpPWpGaD
Nilotinib—CA6—Metabolism—GGT1—sclerosing cholangitis	0.000636	0.000966	CbGpPWpGaD
Nilotinib—CA6—Metabolism—GOT1—sclerosing cholangitis	0.000636	0.000966	CbGpPWpGaD
Nilotinib—ABCB1—Transmembrane transport of small molecules—CFTR—sclerosing cholangitis	0.000631	0.000959	CbGpPWpGaD
Nilotinib—MAPK14—Cellular responses to stress—HIF1A—sclerosing cholangitis	0.000618	0.000938	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism of lipids and lipoproteins—ABCB4—sclerosing cholangitis	0.000609	0.000925	CbGpPWpGaD
Nilotinib—CA7—Metabolism—GGT1—sclerosing cholangitis	0.000594	0.000902	CbGpPWpGaD
Nilotinib—CA7—Metabolism—GOT1—sclerosing cholangitis	0.000594	0.000902	CbGpPWpGaD
Nilotinib—FGR—Hemostasis—NOS2—sclerosing cholangitis	0.000585	0.000889	CbGpPWpGaD
Nilotinib—HCK—Disease—GOT2—sclerosing cholangitis	0.000574	0.000873	CbGpPWpGaD
Nilotinib—CA12—Metabolism—GOT1—sclerosing cholangitis	0.00055	0.000836	CbGpPWpGaD
Nilotinib—CA12—Metabolism—GGT1—sclerosing cholangitis	0.00055	0.000836	CbGpPWpGaD
Nilotinib—CYP2D6—Biological oxidations—GGT1—sclerosing cholangitis	0.000534	0.000811	CbGpPWpGaD
Nilotinib—CYP2C9—Biological oxidations—GGT1—sclerosing cholangitis	0.000529	0.000804	CbGpPWpGaD
Nilotinib—UGT1A1—Metabolism—ABCB4—sclerosing cholangitis	0.000515	0.000782	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000514	0.000782	CbGpPWpGaD
Nilotinib—CA4—Metabolism—GOT2—sclerosing cholangitis	0.000508	0.000772	CbGpPWpGaD
Nilotinib—HCK—Disease—GOT1—sclerosing cholangitis	0.000496	0.000753	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism of lipids and lipoproteins—ABCB4—sclerosing cholangitis	0.000496	0.000753	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000489	0.000743	CbGpPWpGaD
Nilotinib—CA2—Metabolism—GOT2—sclerosing cholangitis	0.000487	0.00074	CbGpPWpGaD
Nilotinib—CA1—Metabolism—GOT2—sclerosing cholangitis	0.000467	0.00071	CbGpPWpGaD
Nilotinib—CA4—Metabolism—GGT1—sclerosing cholangitis	0.000439	0.000667	CbGpPWpGaD
Nilotinib—CA4—Metabolism—GOT1—sclerosing cholangitis	0.000439	0.000667	CbGpPWpGaD
Nilotinib—ABCG2—Metabolism—ABCB4—sclerosing cholangitis	0.000437	0.000664	CbGpPWpGaD
Nilotinib—CA2—Metabolism—GOT1—sclerosing cholangitis	0.000421	0.000639	CbGpPWpGaD
Nilotinib—CA2—Metabolism—GGT1—sclerosing cholangitis	0.000421	0.000639	CbGpPWpGaD
Nilotinib—BRAF—Disease—GOT2—sclerosing cholangitis	0.000411	0.000624	CbGpPWpGaD
Nilotinib—CA9—Metabolism—GOT2—sclerosing cholangitis	0.000411	0.000624	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.00041	0.000623	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000406	0.000617	CbGpPWpGaD
Nilotinib—CA1—Metabolism—GGT1—sclerosing cholangitis	0.000403	0.000613	CbGpPWpGaD
Nilotinib—CA1—Metabolism—GOT1—sclerosing cholangitis	0.000403	0.000613	CbGpPWpGaD
Nilotinib—KIT—Disease—GOT2—sclerosing cholangitis	0.000374	0.000568	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.00037	0.000562	CbGpPWpGaD
Nilotinib—BRAF—Disease—GOT1—sclerosing cholangitis	0.000355	0.000539	CbGpPWpGaD
Nilotinib—CA9—Metabolism—GOT1—sclerosing cholangitis	0.000355	0.000539	CbGpPWpGaD
Nilotinib—CA9—Metabolism—GGT1—sclerosing cholangitis	0.000355	0.000539	CbGpPWpGaD
Nilotinib—PDGFRA—Disease—GOT2—sclerosing cholangitis	0.000354	0.000538	CbGpPWpGaD
Nilotinib—LYN—Hemostasis—NOS2—sclerosing cholangitis	0.000352	0.000535	CbGpPWpGaD
Nilotinib—ABL1—Hemostasis—NOS2—sclerosing cholangitis	0.000351	0.000533	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.00035	0.000532	CbGpPWpGaD
Nilotinib—CYP3A4—Biological oxidations—GGT1—sclerosing cholangitis	0.000349	0.00053	CbGpPWpGaD
Nilotinib—HCK—Disease—HIF1A—sclerosing cholangitis	0.000345	0.000524	CbGpPWpGaD
Nilotinib—MAPK14—Hemostasis—NOS2—sclerosing cholangitis	0.000334	0.000507	CbGpPWpGaD
Nilotinib—KIT—Disease—GOT1—sclerosing cholangitis	0.000323	0.00049	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—ABCB4—sclerosing cholangitis	0.00032	0.000487	CbGpPWpGaD
Nilotinib—PDGFRB—Disease—GOT2—sclerosing cholangitis	0.000319	0.000484	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000315	0.000479	CbGpPWpGaD
Nilotinib—HCK—Disease—NOS2—sclerosing cholangitis	0.000314	0.000477	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000309	0.000469	CbGpPWpGaD
Nilotinib—PDGFRA—Disease—GOT1—sclerosing cholangitis	0.000305	0.000464	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000293	0.000444	CbGpPWpGaD
Nilotinib—LCK—Hemostasis—NOS2—sclerosing cholangitis	0.000289	0.000439	CbGpPWpGaD
Nilotinib—PDGFRB—Disease—GOT1—sclerosing cholangitis	0.000275	0.000418	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—ABCB4—sclerosing cholangitis	0.000271	0.000412	CbGpPWpGaD
Nilotinib—LCK—Disease—GOT2—sclerosing cholangitis	0.000256	0.000389	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000253	0.000384	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism of lipids and lipoproteins—GGT1—sclerosing cholangitis	0.00025	0.000379	CbGpPWpGaD
Nilotinib—BRAF—Disease—HIF1A—sclerosing cholangitis	0.000247	0.000375	CbGpPWpGaD
Nilotinib—UGT1A1—Metabolism—GOT2—sclerosing cholangitis	0.000245	0.000372	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—ABCB4—sclerosing cholangitis	0.000236	0.000359	CbGpPWpGaD
Nilotinib—KIT—Disease—HIF1A—sclerosing cholangitis	0.000225	0.000341	CbGpPWpGaD
Nilotinib—BRAF—Disease—NOS2—sclerosing cholangitis	0.000224	0.000341	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—ABCB4—sclerosing cholangitis	0.000223	0.000338	CbGpPWpGaD
Nilotinib—LCK—Disease—GOT1—sclerosing cholangitis	0.000221	0.000336	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—ABCB4—sclerosing cholangitis	0.000221	0.000335	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000219	0.000332	CbGpPWpGaD
Nilotinib—PDGFRA—Disease—HIF1A—sclerosing cholangitis	0.000213	0.000323	CbGpPWpGaD
Nilotinib—UGT1A1—Metabolism—GOT1—sclerosing cholangitis	0.000211	0.000321	CbGpPWpGaD
Nilotinib—UGT1A1—Metabolism—GGT1—sclerosing cholangitis	0.000211	0.000321	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000208	0.000316	CbGpPWpGaD
Nilotinib—ABCG2—Metabolism—GOT2—sclerosing cholangitis	0.000208	0.000315	CbGpPWpGaD
Nilotinib—KIT—Disease—NOS2—sclerosing cholangitis	0.000204	0.00031	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—sclerosing cholangitis	0.000203	0.000309	CbGpPWpGaD
Nilotinib—PDGFRA—Disease—NOS2—sclerosing cholangitis	0.000193	0.000294	CbGpPWpGaD
Nilotinib—PDGFRB—Disease—HIF1A—sclerosing cholangitis	0.000191	0.000291	CbGpPWpGaD
Nilotinib—ABCG2—Metabolism—GGT1—sclerosing cholangitis	0.000179	0.000272	CbGpPWpGaD
Nilotinib—ABCG2—Metabolism—GOT1—sclerosing cholangitis	0.000179	0.000272	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000174	0.000265	CbGpPWpGaD
Nilotinib—PDGFRB—Disease—NOS2—sclerosing cholangitis	0.000174	0.000265	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000173	0.000262	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000157	0.000239	CbGpPWpGaD
Nilotinib—LCK—Disease—HIF1A—sclerosing cholangitis	0.000154	0.000233	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—GOT2—sclerosing cholangitis	0.000152	0.000231	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000149	0.000226	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—ABCB4—sclerosing cholangitis	0.000146	0.000221	CbGpPWpGaD
Nilotinib—LCK—Disease—NOS2—sclerosing cholangitis	0.00014	0.000212	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000134	0.000204	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—GGT1—sclerosing cholangitis	0.000131	0.0002	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—GOT1—sclerosing cholangitis	0.000131	0.0002	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000131	0.000199	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—GOT2—sclerosing cholangitis	0.000129	0.000196	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000124	0.000189	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—GOT2—sclerosing cholangitis	0.000112	0.000171	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—GOT1—sclerosing cholangitis	0.000111	0.000169	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—GGT1—sclerosing cholangitis	0.000111	0.000169	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000108	0.000163	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—GOT2—sclerosing cholangitis	0.000106	0.000161	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—GOT2—sclerosing cholangitis	0.000105	0.000159	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—GGT1—sclerosing cholangitis	9.69e-05	0.000147	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—GOT1—sclerosing cholangitis	9.69e-05	0.000147	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—GGT1—sclerosing cholangitis	9.13e-05	0.000139	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—GOT1—sclerosing cholangitis	9.13e-05	0.000139	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—GGT1—sclerosing cholangitis	9.05e-05	0.000137	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—GOT1—sclerosing cholangitis	9.05e-05	0.000137	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—GOT2—sclerosing cholangitis	6.91e-05	0.000105	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—GGT1—sclerosing cholangitis	5.97e-05	9.07e-05	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—GOT1—sclerosing cholangitis	5.97e-05	9.07e-05	CbGpPWpGaD
